Construction of a CRISPR‐Biolayer Interferometry Platform for Real‐Time, Sensitive, and Specific DNA Detection

Shan‐Peng Qiao,Zhen‐Ni Liu,Hai‐Chao Li,Xin He,Hong Pan,Yu‐Zhou Gao

DOI: https://doi.org/10.1002/cbic.202100054

IF: 3.2

2021-04-14

ChemBioChem

Abstract:The clustered regularly interspaced short palindromic repeats (CRISPR) technology has been widely applied for nucleic acid detection because of its high specificity. By using the highly specific and irreversible bond between HaloTag and its alkane chlorine ligand, we modified dCas9 (deactivated CRISPR/Cas 9) with biotin as a biosensor to detect nucleic acids. The CRISPR biosensor was facilely prepared to adequately maintain its DNA‐recognition capability. Furthermore, by coupling biolayer interferometry (BLI) with the CRISPR biosensor, a real‐time, sensitive, and rapid digital system called CRISPR–BLI was established for the detection of double‐stranded DNA. The CRISPR biosensor immobilised on the biolayer could recruit the target DNA onto the biosensor surface and change its optical thickness, resulting in a shift in the interference pattern and responding signal of the BLI. The CRISPR–BLI system was further applied to detect the ALP  gene of Escherichia coil DH5α combined with polymerase chain reaction, which demonstrated a linear range from 20 to 20,000 pg and a low detection limit (1.34 pg). The CRISPR–BLI system is a promising approach for rapid and sensitive detection of target DNA analytes.

biochemistry & molecular biology,chemistry, medicinal

What problem does this paper attempt to address?

This paper aims to develop a real - time, sensitive and specific DNA detection system - the CRISPR - BLI platform. Specifically, researchers utilized the high - specific binding ability of CRISPR technology and the real - time detection advantage of Biolayer Interferometry (BLI) to construct a method that can rapidly and sensitively detect target DNA sequences. By combining biotin - modified dCas9 (inactivated CRISPR/Cas9) with single - guide RNA (sgRNA) to form a CRISPR biosensor and immobilizing it on the surface of the BLI sensor, when the target DNA matches the sgRNA on the biosensor, it will trigger a change in optical thickness, resulting in a displacement of the interference pattern and a detectable signal change. In addition, this system also combines the polymerase chain reaction (PCR) amplification technology, further improving the detection sensitivity and achieving accurate detection of low - concentration DNA samples. The study demonstrates the potential of the CRISPR - BLI system in clinical applications, especially in rapidly and sensitively detecting specific gene sequences.